Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature

Neuropsychiatric Disease and Treatment

Volumn 4, Issue 6, 2008, Pages 1089-1109

  Abrams, Daniel J ^a   Rojas, Donald C ^a   Arciniegas, David B ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Manic depressive disorder; Schizoaffective disorder; Schizophrenia

Indexed keywords

CELL PROTEIN; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; BIPOLAR DISORDER; BRAIN ELECTROPHYSIOLOGY; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; ETHNIC DIFFERENCE; GENETIC DISORDER; HUMAN; INCIDENCE; MAJOR DEPRESSION; MOOD DISORDER; NEUROENDOCRINE DISEASE; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMITTER RELEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PREVALENCE; PSYCHIATRIC DIAGNOSIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 60249084936     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/ndt.s4120     Document Type: Review

References (129)

1. Adler CM, Strakowski SM. 2003. Boundaries of schizophrenia. Psychiatr Clin North Am, 26:1-23.
2. American Psychiatric Association, American Psychiatric Association, and Work Group to Revise DSM-III 1987, Diagnostic and statistical manual of mental disorders DSM-III-R, 3rd ed., rev edn, American Psychiatric Association, Washington, DC.
3. Angst J, Felder W, Lohmeyer B. 1980. Course of schizoaffective psychoses: results of a follow-up study. Schizophr Bull, 6:579-85.
4. Angst J, Preisig M. 1995. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr, 146:5-16.
5. Arciniegas DB, Kaufer DI. 2006. Core curriculum for training in behavioral neurology and neuropsychiatry. J Neuropsychiatry Clin Neurosci, 18:6-13.
6. Ardekani BA, Nierenberg J, Hoptman MJ, et al. 2003. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport, 14:2025-9.
7. Baethge C, Gruschka P, Berghofer A, et al. 2004. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up. J Affect Disord, 79(1-3):43-50.
8. Benabarre A, Vieta E, Colom F, et al. 2001. Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences. Eur Psychiatry, 16:167-72.
9. Benson KL, Sullivan EV, Lim KO, et al. 1996. Slow wave sleep and computed tomographic measures of brain morphology in schizophrenia. Psychiatry Res, 60(2-3): 125-34.
10. Benson KL, Zarcone VP, Jr. 1982. Middle ear muscle activity during REM sleep in schizophrenic, schizoaffective and depressed patients. Am J Psychiatry, 139:1474-6.
11. Berner P, Simhandl C. 1983. Approaches to an exact definition of schizoaffective psychoses for research purposes. Psychiatr Clin (Basel), 16(2-4):245-53.
12. Bilder RM, Goldman RS, Volavka J, et al. 2002. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry, 159:1018-28.
13. Bilder RM, Wu H, Bogerts B, et al. 1999. Cerebral volume asymmetries in schizophrenia and mood disorders: a quantitative magnetic resonance imaging study. Int J Psychophysiol, 34:197-205.
14. Borenstein S, Cheron G, Toscano-Aguilar M, et al. 1988. [Comparative study of the amplitude, surface and duration of the pre- and post-imperative waves of the CNV (contingent negative variation) in a group of 40 schizophrenic and schizo-affective patients as compared with normal subjects]. Neurophysiol Clin, 18:129-40.
15. Boutros N, Nasrallah H, Leighty R, et al. 1997. Auditory evoked potentials, clinical vs. research applications. Psychiatry Res, 69(2-3):183-95.
16. Brenner CA, Sporns O, Lysaker PH, et al. 2003. EEG synchronization to modulated auditory tones in schizophrenia, schizoaffective disorder, and schizotypal personality disorder. Am J Psychiatry, 160:2238-40.
17. Bruder G, Kayser J, Tenke C, et al. 1998. The time course of visuospatial processing deficits in schizophrenia: an event-related brain potential study. J Abnorm Psychol, 107:399-411.
18. Bryson G, Bell M, Lysaker P. 1997. Affect recognition in schizophrenia: a function of global impairment or a specific cognitive deficit. Psychiatry Res, 71:105-13.
19. Bryson G, Greig T, Lysaker P, et al. 2002. Longitudinal Wisconsin card sorting performance in schizophrenia patients in rehabilitation. Appl Neuropsychol, 9:203-9.
20. Buchanan RW, Francis A, Arango C, et al. 2004. Morphometric assessment of the heteromodal association cortex in schizophrenia. Am J Psychiatry, 161:322-31.
21. Byerly M, Goodman W, Acholonu W, et al. 2005. Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophr Res, 76(2-3):309-16.
22. Cannon TD, Van Erp TG, Huttunen M, et al. 1998. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry, 55:1084-91.
23. Cannon TD, Van Erp TG, Rosso IM, et al. 2002. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry, 59:35-41.
24. Cardno AG, Holmans PA, Rees MI, et al. 2001. A genomewide linkage study of age at onset in schizophrenia. Am J Med Genet, 105:439-45.
25. Chengappa KN, Parepally H, Brar JS, et al. 2003. A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study. Can J Psychiatry, 48:187-94.
26. Cohen LS. 2003. Gender-specific considerations in the treatment of mood disorders in women across the life cycle. J Clin Psychiatry, 64(Suppl 15): 18-29.
27. Davis JM, Chen N. 2004. Dose response and dose equivalence of antipsychotics. J Clin Psychopharmacol, 24:192-208.
28. del Rio Vega JM, Ayuso-Gutierrez JL. 1990. Course of schizoaffective psychosis: a retrospective study. Acta Psychiatr Scand, 81:534-7.
29. del Rio Vega JM, Ayuso-Gutierrez JL. 1992. Course of schizoaffective psychosis: further data from a retrospective study. Acta Psychiatr Scand, 85:328-30.
30. DeLisi LE, Mesen A, Rodriguez C, et al. 2002. Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica. Am J Med Genet, 114:497-508.
31. Dell'Osso L, Akiskal HS, Freer P, et al. 1993. Psychotic and nonpsychotic bipolar mixed states: comparisons with manic and schizoaffective disorders. Eur Arch Psychiatry Clin Neurosci, 243:75-81.
32. Dick DM, Foroud T, Flury L, et al. 2003. Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am J Hum Genet, 73:107-14.
33. Faraone SV, Skol AD, Tsuang DW, et al. 2002. Linkage of chromosome 13q32 to schizophrenia in a large veterans affairs cooperative study sample. Am J Med Genet, 114:598-604.
34. Faustman WO, Bardgett M, Faull KF, et al. 1999. Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients. Biol Psychiatry, 45:68-75.
35. Frances A, First MB, Pincus HA. 1995, DSM-IV guidebook, 1st ed. Washington, DC: American Pyschiatric Press.
36. Friedlander RI, Donnelly T. 2004. Early-onset psychosis in youth with intellectual disability. J Intellect Disabil Res, 48(Pt 6):540-7.
37. Getz GE, DelBello MP, Fleck DE, et al. 2002. Neuroanatomic characterization of schizoaffective disorder using MRI: a pilot study. Schizophr Res, 55(1-2):55-9.
38. Giouzeli M, Williams NA, Lonie LJ, et al. 2004. ProtocadherinX/Y, a candidate gene-pair for schizophrenia and schizoaffective disorder: a DHPLC investigation of genomic sequence. Am J Med Genet B Neuropsychiatr Genet, 129B:1-9.
39. Glahn DC, Bearden CE, Cakir S, et al. 2006. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord, 8:117-23.
40. Goldstein G, Shemansky WJ, Allen DN. 2005. Cognitive function in schizoaffective disorder and clinical subtypes of schizophrenia. Arch Clin Neuropsychol, 20:153-9.
41. Goode DJ, Manning AA. 1985. Variations in the Hoffmann reflex recovery curve related to clinical manifestations of schizoaffective disorder. Psychiatry Res, 15:63-70.
42. Gooding DC, Tallent KA. 2002. Spatial working memory performance in patients with schizoaffective psychosis versus schizophrenia: a tale of two disorders? Schizophr Res, 53:209-18.
43. Hamshere ML, Bennett P, Williams N, et al. 2005. Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry, 62:1081-8.
44. Harrow M, Grossman LS, Herbener ES, et al. 2000. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry, 177:421-6.
45. Harvey PD, Napolitano JA, Mao L, et al. 2003. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder. Int J Geriatr Psychiatry, 18:820-9.
46. Harvey PD, Siu CO, Romano S. 2004. Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder. Psychopharmacology (Berl), 172:324-32.
47. Hodgkinson CA, Goldman D, Jaeger J, et al. 2004. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet, 75:862-72.
48. Hollis C. 2000. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am J Psychiatry, 157:1652-9.
49. Inui K, Motomura E, Okushima R, et al. 1998. Electroencephalographic findings in patients with DSM-IV mood disorder, schizophrenia, and other psychotic disorders. Biol Psychiatry, 43:69-75.
50. Ishizuka K, Paek M, Kamiya A, et al. 2006. A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol Psychiatry, 59:1189-97.
51. Jurjus GJ, Nasrallah HA, Olson SC, et al. 1993. Cavum septum pellucidum in schizophrenia, affective disorder and healthy controls: a magnetic resonance imaging study. Psychol Med, 23:319-22.
52. Kasanin J. 1994. The acute schizoaffective psychoses. 1933. Am J Psychiatry, 151 (6 Suppl):144-54.
53. Kathmann N, Hochrein A, Uwer R, et al. 2003. Deficits in gain of smooth pursuit eye movements in schizophrenia and affective disorder patients and their unaffected relatives. Am J Psychiatry, 160:696-702.
54. Kayser J, Bruder GE, Friedman D, et al. 1999. Brain event-related potentials (ERPs) in schizophrenia during a word recognition memory task. Int J Psychophysiol, 34:249-65.
55. Kayser J, Bruder GE, Tenke CE, et al. 2001. Event-related brain potentials (ERPs) in schizophrenia for tonal and phonetic oddball tasks. Biol Psychiatry, 49:832-47.
56. Keck PE Jr, McElroy SL, Strakowski SM. 1996. New developments in the pharmacologic treatment of schizoaffective disorder. J Clin Psychiatry, 57(Suppl 9):41-8.
57. Keshavan MS, Stanley JA, Montrose DM, et al. 2003. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study. Mol Psychiatry, 8:316-23, 251.
58. Keshaven MS, Reynolds CF III, Miewald J, et al. 1995. Slow-wave sleep deficits and outcome in schizophrenia and schizoaffective disorder. Acta Psychiatr Scand, 91:289-92.
59. Kirov G, Ivanov D, Williams NM, et al. 2004. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry, 55:971-5.
60. Kolakowska T, Williams AO, Jambor K, et al. 1985. Schizophrenia with good and poor outcome. III: Neurological 'soft' signs, cognitive impairment and their clinical significance. Br J Psychiatry, 146:348-57.
61. Kumar N, Debruille JB. 2004. Semantics and N400: insights for schizophrenia. J Psychiatry Neurosci, 29:89-98.
62. Kumar R, Marks M, Wieck A, et al. 1993. Neuroendocrine and psychosocial mechanisms in post-partum psychosis. Prog Neuropsychopharmacol Biol Psychiatry, 17:571-9.
63. Laruelle M, bi-Dargham A, Casanova MF, et al. 1993. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry, 50:810-8.
64. Lenz G, Simhandl C, Thau K, et al. 1991. Temporal stability of diagnostic criteria for functional psychoses. Results from the Vienna follow-up study. Psychopathology, 24:328-35.
65. Levinson DF, Umapathy C, Musthaq M. 1999. Treatment of schizoaffective disorder and schizophrenia with mood symptoms. Am J Psychiatry, 156:1138-48.
66. Liddle PF, Laurens KR, Kiehl KA, et al. 2006. Abnormal function of the brain system supporting motivated attention in medicated patients with schizophrenia: an fMRI study. Psychol Med, 36:1097-108.
67. Lieberman JA, Jody D, Geisler S, et al. 1993a. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry, 50:369-76.
68. Lieberman JA, Jody D, Alvir JM, et al. 1993b. Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates. Arch Gen Psychiatry, 50:357-68.
69. Liu CM, Hwu HG, Fann CS, et al. 2005. Linkage evidence of schizophrenia to loci near neuregulin 1 gene on chromosome 8p21 in Taiwanese families. Am J Med Genet B Neuropsychiatr Genet, 134:79-83.
70. Maier W. 2006. Do schizoaffective disorders exist at all? Acta Psychiatr Scand, 113:369-71.
71. Maj M, Pirozzi R, Formicola AM, et al. 2000. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. J Affect Disord, 57(1-3):95-8.
72. Malla AK, Norman RM, Scholten D. 2000. Predictors of service use and social conditions in patients with psychotic disorders. Can J Psychiatry, 45:269-73.
73. Manschreck TC, Maher BA, Beaudette SM, et al. 1997. Context memory in schizoaffective and schizophrenic disorders. Schizophr Res, 26(2-3): 153-61.
74. Marder SR, McQuade RD, Stock E, et al. 2003. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res, 61 (2-3):123-36.
75. Marneros A. 2003. The schizoaffective phenomenon: the state of the art. Acta Psychiatr Scand Suppl, 418:29-33.
76. Marneros A, Deister A, Rohde A. 1989a. Quality of affective symptomatology and its importance for the definition of schizoaffective disorders. Psychopathology, 22(2-3):152-60.
77. Marneros A, Deister A, Rohde A. 1990. Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course. Acta Psychiatr Scand, 82:352-8.
78. Marneros A, Deister A, Rohde A. 1991. Stability of diagnoses in affective, schizoaffective and schizophrenic disorders. Cross-sectional versus longitudinal diagnosis. Eur Arch Psychiatry Clin Neurosci, 241:187-92.
79. Marneros A, Deister A, Rohde A, et al. 1989b. Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. I. Definitions, methods, psychopathological and social outcome. Eur Arch Psychiatry Neurol Sci, 238:118-25.
80. McClellan J, McCurry C. 1999. Early onset psychotic disorders: diagnostic stability and clinical characteristics. Eur Child Adolesc Psychiatry, 8(Suppl 1):13-9.
81. McElroy SL, Keck PE Jr, Strakowski SM. 1999. An overview of the treatment of schizoaffective disorder. J Clin Psychiatry, 60(Suppl 5):16-21.
82. Meltzer HY, Arora RC, Metz J. 1984. Biological studies of schizoaffective disorders. Schizophr Bull, 10:49-70.
83. Mitrushina M, Abara J, Blumenfeld A. 1996. A comparison of cognitive profiles in schizophrenia and other psychiatric disorders. J Clin Psychol, 52:177-90.
84. Mokrani M, Duval F, Diep TS, et al. 2000. Multihormonal responses to clonidine in patients with affective and psychotic symptoms. Psychoneuroendocrinology, 25:741-52.
85. Nangle JM, Clarke S, Morris DW, et al. 2006. Neurocognition and suicidal behaviour in an Irish population with major psychotic disorders. Schizophr Res, 85(1-3):196-200.
86. Olincy A, Martin L. 2005. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry, 162:43-9.
87. Oltmanns TF, Murphy R, Berenbaum H, et al. 1985. Rating verbal communication impairment in schizophrenia and affective disorders. Schizophr Bull, 11:292-9.
88. Pini S, de Queiroz V, Dell'Osso L, et al. 2004. Cross-sectional similarities and differences between schizophrenia, schizoaffective disorder and mania or mixed mania with mood-incongruent psychotic features. Eur Psychiatry, 19:8-14.
89. Pope JW, Kern RS. 2006. An "errorful" learning deficit in schizophrenia? J Clin Exp Neuropsychol, 28:101-10.
90. Porteous DJ, Thomson P, Brandon NJ, et al. 2006. The genetics and biology of DISC1 - an emerging role in psychosis and cognition. Biol Psychiatry, 60:123-31.
91. Prasad KM, Rohm BR, Keshavan MS. 2004. Parahippocampal gyrus in first episode psychotic disorders: a structural magnetic resonance imaging study. Prog Neuropsychopharmacol Biol Psychiatry, 28:651-8.
92. Reite M, Teale P, Rojas DC, et al. 1999. Schizoaffective disorder: evidence for reversed cerebral asymmetry. Biol Psychiatry, 46:133-6.
93. Roofeh D, Cottone J, Burdick KE, et al. 2006. Deficits in memory strategy use are related to verbal memory impairments in adolescents with schizophrenia-spectrum disorders. Schizophr Res, 85(1-3):201-12.
94. Saccuzzo DP, Braff DL. 1986. Information-processing abnormalities: trait- and state-dependent components. Schizophr Bull, 12:447-59.
95. Sajatovic M, Mullen JA, Sweitzer DE. 2002. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis. J Clin Psychiatry, 63:1156-63.
96. Schwartz JE, Fennig S, Tanenberg-Karant M, et al. 2000. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch Gen Psychiatry, 57:593-600.
97. Scully PJ, Owens JM, Kinsella A, et al. 2004. Schizophrenia, schizoaffective and bipolar disorder within an epidemiologically complete, homogeneous population in rural Ireland: small area variation in rate. Schizophr Res, 67(2-3): 143-55.
98. Segurado R, tera-Wadleigh SD, Levinson DF, et al. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet, 73:49-62.
99. Sharma RP, Bissette G, Janicak P, et al. 1994. Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment. Schizophr Res, 13:173-7.
100. Sharma RP, Faull K, Javaid JI, et al. 1995. Cerebrospinal fluid levels of phenylacetic acid in mental illness: behavioral associations and response to neuroleptic treatment. Acta Psychiatr Scand, 91:293-8.
101. Sharma RP, Janicak PG, Bissette G, et al. 1997, CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder. Am J Psychiatry, 154:1019-21.
102. Sharma RP, Javaid JI, Davis JM, et al. 1998. Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence of demographic variables and the inpatient drug-free period. Biol Psychiatry, 44:488-92.
103. Sharma RP, Javaid JI, Janicak PG, et al. 1993. Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment. Biol Psychiatry, 34:128-34.
104. Shenton ME, Solovay MR, Holzman P. 1987. Comparative studies of thought disorders. II. Schizoaffective disorder. Arch Gen Psychiatry, 44:21-30.
105. Skol AD, Young KA, Tsuang DW, et al. 2003. Modest evidence for linkage and possible confirmation of association between NOTCH4 and schizophrenia in a large Veterans Affairs Cooperative Study sample. Am J Med Genet B Neuropsychiatr Genet, 118:8-15.
106. Spitzer RL, Endicott J, Robins E. 1978. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry, 35:773-82.
107. Staddon S, Arranz MJ, Mancama D, et al. 2005. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population. Schizophr Res, 73:49-54.
108. Stip E, Sepehry AA, Prouteau A, et al. 2005. Cognitive discernible factors between schizophrenia and schizoaffective disorder. Brain Cogn, 59:292-5.
109. Stone WS, Thermenos HW, Tarbox SI, et al. 2005. Medial temporal and prefrontal lobe activation during verbal encoding following glucose ingestion in schizophrenia: A pilot fMRI study. Neurobiol Learn Mem, 83:54-64.
110. Strakowski SM, Keck PE Jr, Arnold LM, et al. 2003. Ethnicity and diagnosis in patients with affective disorders. J Clin Psychiatry, 64:747-54.
111. Strauss JL, Calhoun PS, Marx CE, et al. 2006. Comorbid posttraumatic stress disorder is associated with suicidality in male veterans with schizophrenia or schizoaffective disorder. Schizophr Res, 84:165-9.
112. Szeszko PR, Ardekani BA, Ashtari M, et al. 2005. White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry, 162:602-5.
113. Teale P, Reite M, Rojas DC, et al. 2000. Fine structure of the auditory M100 in schizophrenia and schizoaffective disorder. Biol Psychiatry, 48:1109-12.
114. Tohen M, Strakowski SM, Zarate C Jr, et al. 2000. The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry, 48:467-76.
115. Tohen M, Zhang F, Keck PE, et al. 2001. Olanzapine versus haloperidol in schizoaffective disorder, bipolar type. J Affect Disord, 67(1-3):133-40.
116. Tsuang D, Coryell W. 1993. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry, 150:1182-8.
117. Ujike H, Takehisa Y, Takaki M, et al. 2001. NOTCH4 gene polymorphism and susceptibility to schizophrenia and schizoaffective disorder. Neurosci Lett, 301:41-4.
118. Van Erp TG, Saleh PA, Huttunen M, et al. 2004. Hippocampal volumes in schizophrenic twins. Arch Gen Psychiatry, 61:346-53.
119. Vieta E, Herraiz M, Fernandez A, et al. 2001. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD). J Clin Psychiatry, 62:623-30.
120. Vollmer-Larsen A, Jacobsen TB, Hemmingsen R, et al. 2006. Schizoaffective disorder - the reliability of its clinical diagnostic use. Acta Psychiatr Scand, 113:402-7.
121. Weiss J, Magert HJ, Cieslak A, et al. 1996. Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls. Eur J Med Res, 1:439-45.
122. Werry JS, McClellan JM, Chard L. 1991. Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study. J Am Acad Child Adolesc Psychiatry, 30:457-65.
123. Whaley AL. 2002. Symptom clusters in the diagnosis of affective disorder, schizoaffective disorder, and schizophrenia in African Americans. J Natl Med Assoc, 94:313-9.
124. Wijsman EM, Rosenthal EA, Hall D, et al. 2003. Genome-wide scan in a large complex pedigree with predominantly male schizophrenics from the island of Kosrae: evidence for linkage to chromosome 2q. Mol Psychiatry, 8:695-705, 643.
125. Willour VL, Zandi PP, Huo Y, et al. 2003. Genome scan of the fifty-six bipolar pedigrees from the NIMH genetics initiative replication sample: chromosomes 4, 7, 9, 18, 19, 20, and 21. Am J Med Genet B Neuropsychiatr Genet, 121:21-7.
126. Wilson M. 1993. DSM-III and the transformation of American psychiatry: a history. Am J Psychiatry, 150:399-410.
127. Winokur G, Monahan P, Coryell W, et al. 1996. Schizophrenia and affective disorder - distinct entities or continuum? An analysis based on a prospective 6-year follow-up. Compr Psychiatry, 37:77-87.
128. Woodward TS, Thornton AE, Ruff CC, et al. 2004. Material-specific episodic memory associates of the psychomotor poverty syndrome in schizophrenia. Cognit Neuropsychiatry, 9:213-27.
129. Zarate CA Jr, Tohen M, Baraibar G, et al. 1997. Shifts in hospital diagnostic frequencies: bipolar disorder subtypes, 1981-1993. J Affect Disord, 43:79-84.